H. Lundbeck A/S Presents Phase Ib Data, Starts Phase II Study
H. Lundbeck A/S announced results from a Phase Ib study for Lu AF28996 in advanced Parkinson's disease and has initiated a Phase II study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.